Brought to you by 
Medtronic buys VidaMed for $326mm in cash
Dec 2001
Executive Summary
Medtronic has agreed to acquire VidaMed (minimally invasive urological surgery devices) for $326mm in cash. Medtronic will pay VidaMed shareholders $7.91 per share (a 35% premium to market average) for all outstanding equity of VidaMed. VidaMed will become a wholly owned subsidiary of Medtronic.
Deal Industry
-
Medical Devices
- Radiofrequency Devices
- Surgical Equipment & Devices
- Therapeutic Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Payment Includes Cash
- Includes Contract
- Full Acquisition
Already a Strategic Transactions subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Medtronic buys VidaMed for $326mm in cash
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice